SomnoMed Limited
(ASX:SOM) is continuing its bumper year growing revenues a further 17.3 per cent during the third quarter.
March was a highlight with total revenues of $3.03 million up 28 per cent on March last year and providing the company’s second highest unit sales month in its history.
US sales are a standout growing 31 per cent in March after flat sales in January and February.
Growth is picking up in Europe, Korea and Japan and the company is confident of setting a new record in fourth quarter sales to the end of the financial year.
SomnoMed reported a net loss of $45,000 for the first six months of the 2015 financial year.
